Adrenal hormone deprivation affects macrophage catecholamine metabolism and β2-adrenoceptor density, but not propranolol stimulation of tumour necrosis factor-α production

Experimental Physiology

Volumn 98, Issue 3, 2013, Pages 665-678

  Stanojević, Stanislava ^a   Dimitrijević, Mirjana ^a   Kuštrimović, Nataša ^a   Mitić, Katarina ^a   Vujić, Vesna ^b   Leposavić, Gordana ^c  

^a Immunology Research Center Belgrade   (Yugoslavia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; GLUCOCORTICOID; MESSENGER RNA; NITRIC OXIDE; NORADRENALIN; PROPRANOLOL; TUMOR NECROSIS FACTOR ALPHA;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANTIBODY LABELING; ARTICLE; CATECHOLAMINE METABOLISM; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNE FUNCTION TEST; IN VITRO STUDY; MACROPHAGE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

EID: 84874114458     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2012.070524     Document Type: Article

References (45)

1. Aarons RD, Nies AS, Gal J, Hegstrand LR & Molinoff PB (1980). Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest 65, 949-957.
2. Abrass CK, O'Connor SW, Scarpace PJ & Abrass IB (1985). Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. J Immunol 135, 1338-1341.
3. Agelaki S, Tsatsanis C, Gravanis A & Margioris AN (2002). Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect Immun 70, 6068-6074.
4. Barish GD, Downes M, Alaynick WA, Yu RT, Ocampo CB, Bookout AL, Mangelsdorf DJ & Evans RM (2005). A nuclear receptor atlas: macrophage activation. Mol Endocrinol 19, 2466-2477.
5. Boost KA, Flondor M, Hofstetter C, Platacis I, Stegewerth K, Hoegl S, Nguyen T, Muhl H & Zwissler B (2007). The beta-adrenoceptor antagonist propranolol counteracts anti-inflammatory effects of isoflurane in rat endotoxemia. Acta Anaesthesiol Scand 51, 900-908.
6. Chrousos GP (2000). Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J Allergy Clin Immunol 106, S275-S291.
7. Cosentino M & Marino F (2012). Noradrenaline and adrenaline. In Nerve-Driven Immunity - Neurotransmitters and Neuropeptides in the Immune System, ed. Levite M, pp. 47-96. Springer-Verlag, Wien .
8. Damoiseaux JGMC, Dopp EA, Calame W, Chao D, MacPherson GG & Dijkstra CD (1994). Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 83, 140-147.
9. 1b adrenoceptor mRNA in corticotropin-releasing hormone-containing cells of the rat hypothalamus and its regulation by corticosterone. J Neurosci 19, 10098-10106.
10. Dimitrijević M, Pilipović I, Stanojević S, Mitić K, Radojević K, Pesić V & Leposavić G (2009). Chronic propranolol treatment affects expression of adrenoceptors on peritoneal macrophages and their ability to produce hydrogen peroxide and nitric oxide. J Neuroimmunol 211, 56-65.
11. Donnelly S, O'Neill SM, Sekiya M, Mulcahy G & Dalton JP (2005). Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Infect Immun 73, 166-173.
12. Edelstein SB & Breakefield XO (1986). Monoamine oxidases A and B are differentially regulated by glucocorticoids and "aging" in human skin fibroblasts. Cell Mol Neurobiol 6, 121-150.
13. Elenkov IJ, Wilder RL, Chrousos GP & Vizi ES (2000). The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52, 595-638.
14. Engler KL, Rudd ML, Ryan JJ, Stewart JK & Fischer-Stenger K (2005). Autocrine actions of macrophage-derived catecholamines on interleukin-1β. J Neuroimmunol 160, 87-91.
15. Felten DL, Felten SY, Carlson SL, Olschowka JA & Livnat S (1985). Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 135, 755s-765s.
16. Flierl MA, Rittirsch D, Nadeau BA, Chen AJ, Sarma JV, Zetoune FS, McGuire SR, List RP, Day DE, Hoesel LM, Gao H, Van Rooijen N, Huber-Lang MS, Neubig RR & Ward PA (2007). Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449, 721-725.
17. Girod JP & Brotman DJ (2004). Does altered glucocorticoid homeostasis increase cardiovascular risk Cardiovasc Res 64, 217-226.
18. 15N]nitrate in biological fluids. Anal Biochem 126, 131-138.
19. 2-adrenoreceptor activation. Am J Physiol Endocrinol Metab 273, E1203-E1208.
20. Haskó G, Shanley TP, Egnaczyk G, Németh ZH, Salzman AL, Vizi ES & Szabó C (1998). Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1αvia a β adrenoceptor mediated mechanism. Br J Pharmacol 125, 1297-1303.
21. Izeboud CA, Mocking JA, Monshouwer M, van Miert AS & Witkamp RF (1999). Participation of β-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. J Recept Signal Transduct Res 19, 191-202.
22. Kamath AB, Nagarkatti PS & Nagarkatti M (1998). Characterization of phenotypic alterations induced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on thymocytes in vivo and its effect on apoptosis. Toxicol Appl Pharmacol 150, 117-124.
23. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL & Chrousos GP (1991). Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254, 421-423.
24. Kavelaars A (2002). Regulated expression of α-1 adrenergic receptors in the immune system. Brain Behav Immun 16, 799-807.
25. Kvetnansky R, Sabban EL & Palkovits M (2009). Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev 89, 535-606.
26. Madden KS, Sanders VM & Felten DL (1995). Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol 35, 417-448.
27. Mak JCW, Nishikawa M, Shirasaki H, Miyayasu K & Barnes PJ (1995). Protective effects of a glucocorticoid on downregulation of pulmonary β2-adrenergic receptors in vivo. J Clin Invest 96, 99-106.
28. Markey KA & Sze PY (1980). Adrenal influence on tyrosine hydroxylase activity in superior cervical ganglion. Brain Res 202, 347-356.
29. Modelska K, Matthay MA, Brown LAS, Deutch E, Lu LN & Pittet JF (1999). Inhibition of β-adrenergic-dependent alveolar epithelial clearance by oxidant mechanisms after hemorrhagic shock. Am J Physiol Lung Cell Mol Physiol 276, L844-L857.
30. Nance DM & Sanders VM (2007). Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 21, 736-745.
31. Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T, Mukundan L, Brombacher F, Locksley RM & Chawla A (2011). Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480, 104-108.
32. Ou XM, Chen K & Shih JC (2006). Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1. J Biol Chem 281, 21512-21525.
33. Papasian CJ, Qureshi N & Morrison DC (2006). Endogenous and exogenous glucocorticoids in experimental enterococcal infection. Clin Vaccine Immunol 13, 349-355.
34. Park C, Kang M, Kim-Kwon Y, Kim J, Ahn H & Huh Y (2002). Inhibition of neuronal nitric oxide synthase increases adrenalectomy-induced granule cell death in the rat dentate gyrus. Brain Res 933, 81-84.
35. Peters DA & Mazurkiewicz-Kwilecki IM (1975). Tyrosine hydroxylase activity in rat brain regions after chronic treatment with +/-- propranolol. J Pharm Pharmacol 27, 671-676.
36. Radojcic T, Baird S, Darko D, Smith D & Bulloch K (1991). Changes in beta-adrenergic receptor distribution on immunocytes during differentiation: an analysis of T cells and macrophages. J Neurosci Res 30, 328-335.
37. Raine AE & Chubb IW (1977). Long term beta-adrenergic blockade reduces tyrosine hydroxylase and dopamine beta-hydroxylase activities in sympathetic ganglia. Nature 267, 265-267.
38. Robinson BG, Emanuel RL, Frim DM & Majzoub JA (1988). Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci U S A 85, 5244-5248.
39. Spengler RN, Chensue SW, Giacherio DA, Blenk N & Kunkel SL (1994). Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. J Immunol 152, 3024-3031.
40. Stout RD & Suttles J (2004). Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 76, 509-513.
41. Tuckermann JP, Kleiman A, McPherson KG & Reichardt HM (2005). Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit Rev Clin Lab Sci 42, 71-104.
42. Tuross N & Patrick RL (1986). Effects of propranolol on catecholamine synthesis and uptake in the central nervous system of the rat. J Pharmacol Exp Ther 237, 739-745.
43. Wang W, Zhang X, Yang L, Liu D, Liu G & Zhou J (2012). Lipopolysaccharide upregulates the expression of corticotropin-releasing hormone via MAP kinase pathway in rat peritoneal macrophages. Mol Cell Biochem 361, 1-7.
44. Wolfe BB, Harden TK & Molinoff PB (1976). β-Adrenergic receptors in rat liver: effects of adrenalectomy. Proc Natl Acad Sci U S A 73, 1343-1347.
45. 2 restrains macrophage maturation via E prostanoid receptor 2/protein kinase A signaling. Blood 119, 2358-2367.